First-of-a-kind stem-cell therapies set for approval in Japan
• Japan’s health ministry grants conditional approval to two pioneering stem‑cell therapies, Amchepry and ReHeart. • Amchepry targets Parkinson’s disease using iPSC‑derived progeni
Clinicaltrials